XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of September 18, 2026, XRTX trades at $1.96 with a market cap of $3.23M and a P/E ratio of 0.00. XRTX moved +24.10% today. Year to date, XRTX is -41.75%; over the trailing twelve months it is -60.95%. Its 52-week range spans $1.59 to $7.05. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks XRTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.96 |
| Market Cap | $3.23M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.05 |
| 52-Week Low | $1.59 |
| Volume | 5.52M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
XRTX analyst coverage data. Average price target: $0.00.